Literature DB >> 29016197

Nutritional Therapy for Patients with Esophageal Cancer.

Taja Jordan1, Denis Mlakar Mastnak2, Nizra Palamar2, Nada Rotovnik Kozjek2.   

Abstract

Malnutrition develops in 79% patients with esophageal cancer. Thus, these patients represent a group of cancer patients, which is the most nutritionally compromised. Dysphagia and more than 10% loss of body weight are already present at the time of diagnosis. Treatments for esophageal cancer contribute significantly to the development of malnutrition. This paper describes the nutritional treatment of patients and nutritional strategies in patients with dysphagia and other nutritional problems that accompany the treatment of patients with esophageal cancer. Here are shown the types and methods of nutritional support, which are suitable for this group of patients. Nutritional support of patients with esophageal cancer is performed as a parallel therapeutic route.

Entities:  

Mesh:

Year:  2017        PMID: 29016197     DOI: 10.1080/01635581.2017.1374417

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  21 in total

1.  Comparison of Introducer Percutaneous Endoscopic Gastrostomy with Open Gastrostomy in Advanced Esophageal Cancer Patients.

Authors:  Prasit Mahawongkajit; Ajjana Techagumpuch; Palin Limpavitayaporn; Amonpon Kanlerd; Ekkapak Sriussadaporn; Jatupong Juntong; Assanee Tongyoo; Chatchai Mingmalairak
Journal:  Dysphagia       Date:  2019-04-25       Impact factor: 3.438

2.  The predictive value of the prognostic nutritional index to postoperative prognosis and nursing intervention measures for colorectal cancer.

Authors:  Yongmei Zhu; Lihua Fan; Xuefeng Geng; Jing Li
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

3.  Clinical Effect and Postoperative Pain of Laparo-Thoracoscopic Esophagectomy in Patients with Esophageal Cancer.

Authors:  Yue Yu; Yun Han
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-26       Impact factor: 2.650

4.  Preoperative transferrin level is a novel indicator of short- and long-term outcomes after esophageal cancer surgery.

Authors:  Taishi Yamane; Hiroshi Sawayama; Naoya Yoshida; Takeshi Morinaga; Takahiko Akiyama; Kojiro Eto; Kazuto Harada; Katsuhiro Ogawa; Masaaki Iwatsuki; Shiro Iwagami; Yoshifumi Baba; Yuji Miyamoto; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2021-09-29       Impact factor: 3.402

Review 5.  The Involvement of WDHD1 in the Occurrence of Esophageal Cancer as a Downstream Target of PI3K/AKT Pathway.

Authors:  Qingying Xian; Danxia Zhu
Journal:  J Oncol       Date:  2022-04-05       Impact factor: 4.375

6.  Impact Exerted by Nutritional Risk Screening on Clinical Outcome of Patients with Esophageal Cancer.

Authors:  Rui Wang; Hongfei Cai; Yang Li; Caiwen Chen; Youbin Cui
Journal:  Biomed Res Int       Date:  2018-03-27       Impact factor: 3.411

7.  Definitive radiochemotherapy in esophageal cancer - a single institution experience.

Authors:  Franc Anderluh; Miha Toplak; Vaneja Velenik; Irena Oblak; Ajra Secerov Ermenc; Ana Jeromen Peressutti; Jasna But-Hadzic; Marija Skoblar Vidmar
Journal:  Radiol Oncol       Date:  2019-11-20       Impact factor: 2.991

8.  Intensity-modulated radiotherapy does not decrease the risk of malnutrition in esophageal cancer patients during radiotherapy compared to three-dimensional conformal radiation therapy.

Authors:  Cong Wang; Ming Lu; Tingting Zhou; Shasha Zhao; Shanghui Guan
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

9.  [Palliative endoscopy].

Authors:  Benno Arnstadt; Hans-Dieter Allescher
Journal:  Chirurg       Date:  2021-06-17       Impact factor: 0.955

10.  Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer.

Authors:  Han Gyul Yoon; Dongryul Oh; Yong Chan Ahn; Jae Myoung Noh; Hongryull Pyo; Won Kyung Cho; Yun Mi Song; Minsu Park; Na Young Hwang; Jong-Mu Sun; Hong Kwan Kim; Jae Ill Zo; Young Mog Shim
Journal:  Cancers (Basel)       Date:  2020-04-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.